US 6133256
Selective factor Xa inhibitors
expired A61KA61K38/00A61P
Quick answer
US patent 6133256 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- COR Therapeutics, Inc.
- Grant date
- Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P7/02, A61P9/00